LT - Iš HuCAL GOLD gautų pilnai žmogaus terapinių antikūnų, specifinių žmogaus CD38, gamyba ir profiliavimas
EN - Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
C07K 16/40 |
(2006.01) |
|
|
C07K 16/30 |
(2006.01) |
|
|
G01N 33/574 |
(2006.01) |
|
|
A61K 39/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2860192 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
14196972.5 |
|
Date of filing the European patent application |
2006-10-12 |
| (97) |
Date of publication of the European application |
2015-04-15 |
| (45) |
Date of publication and mention of the grant of the patent |
2017-09-27
|
| (46) |
Date of publication of the claims translation |
2017-12-11
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
725297 P |
2005-10-12
|
US |
Inventors
| (72) |
Tesar, Michael, DE
Jäger, Ute, DE
|
Grantee
| (73) |
MorphoSys AG,
Semmelweisstrasse 7, 82152 Planegg,
DE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Iš HuCAL GOLD gautų pilnai žmogaus terapinių antikūnų, specifinių žmogaus CD38, gamyba ir profiliavimas |
| |
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38 |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-09-18 |
19 |
347.00
EUR
|
Next renewal fee
|
2025-10-12 |
